Neurocrine Biosciences, Inc.

12780 El Camino Real, San Diego, CA 9213

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company’s portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company’s commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson’s disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor.

Click to rate this company
[Total: 0 Average: 0]

3.7

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

Neurocrine Biosciences asserts its environmental consciousness through a multifaceted approach to sustainability, incorporating energy-efficient technologies, responsible waste management practices, and supply chain optimization, all harmonized to minimize its ecological footprint and promote resource efficiency, translating its dedication to environmental stewardship into tangible actions that reflect its commitment to fostering a healthier planet and a sustainable future.An exemplar of positive social impact, Neurocrine Biosciences centers its mission on improving patient lives and global health, channeling its innovative therapies toward addressing unmet medical needs, while actively engaging in patient advocacy, community outreach, and healthcare education initiatives, thereby amplifying its positive footprint and contributing to societal well-being through accessible and transformative healthcare solutions. Neurocrine Biosciences’ dedication to research excellence and innovation underpins its ESG sustainability strategy, manifested through its commitment to pioneering therapies that address complex medical challenges, enhance patient outcomes, and advance medical science while adhering to rigorous research ethics, clinical integrity, and patient-centric principles that underscore its role as a torchbearer of innovative healthcare solutions.The cornerstone of its ESG framework, Neurocrine Biosciences’ governance and ethics practices resonate with the highest standards of transparency, accountability, and ethical behavior, as exemplified by its diverse and experienced board of directors, robust compliance measures, and a corporate culture that prizes integrity, responsible decision-making, and adherence to regulatory standards, fostering a harmonious convergence of stakeholder interests and corporate values.Neurocrine Biosciences’ financial sustainability finds resonance in its ability to develop and commercialize cutting-edge healthcare solutions that deliver value to patients and healthcare professionals alike, thereby reinforcing a symbiotic relationship between its ESG commitments and long-term financial success, while attracting investors who recognize the intrinsic worth of responsible innovation and sustainable business practices.Neurocrine Biosciences, Inc., an innovative biopharmaceutical company dedicated to enhancing patient lives through scientific discovery and healthcare solutions, exemplifies a comprehensive commitment to ESG (Environment, Social, Governance) sustainability that traverses a complex tapestry of interconnected dimensions, epitomizing a forward-thinking approach to responsible corporate practices that resonate across its operations, products, and partnerships, rooted in a steadfast dedication to ethical conduct, positive societal impact, and transparent governance, while continually striving to align its strategic objectives with the needs of patients, communities, and global stakeholders, thereby fostering a culture of innovation, collaboration, and corporate responsibility within the dynamic realm of biotechnology.

Eligible Awards

Coming Soon





Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$1,400,000,000.00

Website Traffic

Employee Rating

4.1

Customer Rating

3.6

Company Size

100-1000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.